(Q35692948)

9 August 2017

title

CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis (English)

1 reference

9 August 2017

0 references

Daniela Dreymueller

5

0 references

John Penders

object named as

John Penders

13

0 references

Andreas Ludwig

object named as

Andreas Ludwig

8

0 references

author name string

Kai Markus Schneider

1

1 reference

9 August 2017

Veerle Bieghs

2

1 reference

9 August 2017

Felix Heymann

3

1 reference

9 August 2017

Wei Hu

4

1 reference

9 August 2017

Lijun Liao

6

1 reference

9 August 2017

Mick Frissen

7

1 reference

9 August 2017

Nikolaus Gassler

9

1 reference

9 August 2017

Oliver Pabst

10

1 reference

9 August 2017

Eicke Latz

11

1 reference

9 August 2017

Gernot Sellge

12

1 reference

9 August 2017

Frank Tacke

14

1 reference

9 August 2017

Christian Trautwein

15

1 reference

9 August 2017

language of work or name

English

0 references

publication date

14 July 2015

1 reference

9 August 2017

1 reference

9 August 2017

volume

62

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

1405-1416

1 reference

Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic

9 August 2017

cites work

1 reference

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

Pathogenesis of non-alcoholic fatty liver disease.

21 January 2018

1 reference

The fractalkine/CX3CR1 system regulates β cell function and insulin secretion

21 January 2018

1 reference

Circulating fractalkine levels predict the development of the metabolic syndrome

21 January 2018

1 reference

Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

21 January 2018

1 reference

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques

21 January 2018

1 reference

Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences

21 January 2018

1 reference

Functional interactions between the gut microbiota and host metabolism

21 January 2018

1 reference

Understanding the role of gut microbiome in metabolic disease risk.

21 January 2018

1 reference

Intestinal macrophages: well educated exceptions from the rule

21 January 2018

1 reference

CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance

21 January 2018

1 reference

CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice

21 January 2018

1 reference

Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells

21 January 2018

1 reference

Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis

21 January 2018

1 reference

Interactions between the intestinal microbiome and liver diseases

21 January 2018

1 reference

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria

21 January 2018

1 reference

Linking intestinal homeostasis and liver disease

21 January 2018

1 reference

Liver fibrosis in 2012: Convergent pathways that cause hepatic fibrosis in NASH.

21 January 2018

1 reference

Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion

21 January 2018

1 reference

Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents

21 January 2018

1 reference

Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.

21 January 2018

1 reference

The innate immune response during liver inflammation and metabolic disease

21 January 2018

1 reference

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

21 January 2018

1 reference

Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium.

21 January 2018

1 reference

Microbiota-liver axis in hepatic disease.

21 January 2018

1 reference

Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm

21 January 2018

1 reference

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors

21 January 2018

1 reference

Macrophages in intestinal homeostasis and inflammation

21 January 2018

1 reference

Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity

21 January 2018

1 reference

NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice.

21 January 2018

1 reference

NLRP3 inflammasome activation is required for fibrosis development in NAFLD.

21 January 2018

1 reference

NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion

21 January 2018

1 reference

NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis

21 January 2018

1 reference

The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis

21 January 2018

1 reference

TLR4 links innate immunity and fatty acid-induced insulin resistance

21 January 2018

1 reference

Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes

21 January 2018

1 reference

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

21 January 2018

1 reference

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling

21 January 2018

1 reference

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

21 January 2018

1 reference

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

21 January 2018

1 reference

Prevalence of Hepatobiliary Dysfunction in a Regional Group of Patients with Chronic Inflammatory Bowel Disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

7 January 2021

Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype

1 reference

7 January 2021

Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells

1 reference

7 January 2021

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

1 reference

7 January 2021

The fractalkine/Cx3CR1 system is implicated in the development of metabolic visceral adipose tissue inflammation in obesity

1 reference

7 January 2021

Artificial sweeteners induce glucose intolerance by altering the gut microbiota

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.27982

1 reference

9 August 2017

1 reference